Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00178828
Status:
COMPLETED
Last Update Posted:
2017-04-11
First Post:
2005-09-12
Brief Title:
Dynamic Measures of Neurochemistry in Mood Disorders
Sponsor:
Vanderbilt University Medical Center
Organization:
Vanderbilt University Medical Center
Study Overview
Official Title:
Dynamic Measures of Neurochemistry in Mood Disorders
Status:
COMPLETED
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to understand changes in brain chemical signals when people take antidepressants called sertraline Zoloft and bupropion Wellbutrin SR Zyban Spinal fluid is used to measure chemical levels of dopamine serotonin and other chemicals thought to be involved in depression The study has potential to help understand and treat depression
Detailed Description:
The purpose of this study is to understand changes in brain chemical signals when people take antidepressants called sertraline Zoloft and bupropion Wellbutrin SR Zyban Spinal fluid is used to measure chemical levels of dopamine serotonin and other chemicals thought to be involved in depression The study has potential to help understand and treat depression
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5K23MH001828-03 | NIH | None | httpsreporternihgovquickSearch5K23MH001828-03 |